Evaluating Tranexamic Acid (TXA) in Children with Traumatic Injuries (TIC-TOC)

← Back to all studies

Evaluating Tranexamic Acid (TXA) in Children with Traumatic Injuries (TIC-TOC)

Health Categories: Trauma
Health Impacts Domain: —

Summary

This pilot and feasibility study is a double-blind, randomized controlled trial of 40 patients to provide safety and efficacy data on the use of TXA in severely injured children with torso and/or head injuries. Recent evidence in injured adults indicates that treatment with tranexamic acid (TXA) decreases mortality and blood-transfusion requirements following traumatic hemorrhage; however, TXA has not been appropriately studied in children with hemorrhagic injuries.

Key Publications

Related Media

—

Study Details

Long Name
Evaluating Tranexamic Acid in Children with Traumatic Injuries
Short Name
TIC-TOC
Principal Investigator(s)
—
PECARN Node
—

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.